Member Info for Sausageonstick

My average is my average, I'm not going to post details such as that and you won't find many stoopid enough to post their average. You can think what you like, you have no idea what I'm invested in or at what price, nor do you need to know, but you are 5% down in ROQ.

"Why have you been posting on that bulletin board since at least 2018?" Because I want to!! FFS, please just go back to Twitter and repost a few more of your mates tweets.

keep posting watermelon mate, all the ****e your coming out with tells people more about you than it does me.

like i say, stick to twitter.

Stick to watching season one of The Killing mate.

How would you even know what I'm invested in? Do you post on every board you're invested in?

Run along, probably best you stick to twitter.

Watermelon,

The answer is no, but I'm guessing you're down big time in roq.

...presentations at conferences rather than releasing the data to be peer reviewed that's the worry for me.

Interesting reads

https://www.businessinsider.com/theranos-used-its-scientific-conference-presentation-to-unveil-its-new-products-and-people-werent-loving-it-2016-8?r=US&IR=T

https://www.fiercebiotech.com/medical-devices/theranos-finally-presents-data-but-answers-no-questions

https://uk.sports.yahoo.com/news/one-during-theranos-presentation-yesterday-181300473.html

https://arstechnica.com/science/2016/08/elizabeth-holmes-is-finally-presenting-theranos-data-as-company-collapses/

...how many people actually know what the RNS means?

"in vitro Results" where by "in vitro" is "performed or taking place in a test tube, culture dish, or elsewhere outside a living organism." This isn't even in clinical trial, it's in a 'test tube' with some unnamed statistical test applied to it. They don't even publish the p-value, whereby a p-value of 5% or lower is considered statistically significant.

As someone just stated, none of these tests have been released for peer review.

The RNS today, in my opinion, was just an attempt to promote the company without hard and fast evidence. The RNS attempts to link ROQ to Pfizer, Moderna and BioNTech. I've personally never seen a RNS with an extensive bibliography. It's like they feel people are not believing them unless they can come up with a random reference that in some way reinforces what they are saying in RNSs but has not yet happened with regards releasing the data and statistical tests for peer review.

Ask your self why they haven't yet released anything, as far as I can see, but correct me if I'm wrong, for peer review?

What are they scared of?

Todays RNS reminded me of an article I recently read on Elizabeth Holmes and Theranos

https://news.sky.com/story/elizabeth-holmes-how-theranos-founder-went-from-billionaire-darling-of-silicon-valley-to-the-brink-of-prison-12748760#:~:text=Elizabeth%20Holmes%20became%20America's%20youngest,quickly%20as%20it%20had%20risen.

I found the following from the article interesting

"As Eric Jackson, a startup founder and author of The PayPal Wars, put it to Sky News: "There is almost endemic to the system a need to, I don't want to say exaggerate, but to tell a narrative that's compelling to investors. At a certain point hype does have to be in line with credibility, if not you're in an instance of good old-fashioned fraud.""

It's becoming clearer to me by the day, the more time I spent research ROQ personnel. The commonality of why these people appear in the media is for me eye popping.

https:// forbetterscience .com/2019/07/15/questionable-activities-of-uk-company-celixir-by-patricia-murray/

https://forbetterscience .com/2019/04/04/sir-martin-and-ajan-the-stem-cell-gold-diggers/

https://www. ft .com/content/41a4e01a-d3b6-11de-8caf-00144feabdc0

You have to ask yourself, if you were a big pharma now and did your DD on buying ROQ or investing in ROQ wouldn't you want answers on ROQ's personnel's back stories??

Just watched the IG.com interview with Ajan (https://www.youtube.com/watch?v=cvRtMDvdPLU)

Had to chuckle when he said (12m:45s) 'if we deliver our milestones and the data for the last 15 years is accurate'

Have that statement about data being accurate in mind when you read the publicly available article

https://forbetterscience.com/2019/07/15/questionable-activities-of-uk-company-celixir-by-patricia-murray/

Ajan talks about data over the last 15 years, which covers the period that the Celixir Greek trial in Patricia's Murrays article.

Questions

Will the data obtained in the Greek trials be included in ROQ clinical data?

Will the data for the last 15 years be accurate?

Having watched the IG.com interview with Ajan (https://www.youtube.com/watch?v=cvRtMDvdPLU) where he states (12m:45s) 'if ....... the data for the last 15 years is accurate' I continue to wonder where ROQ are going to get 15 years of data from. Does it include research from Celixir? Where Ajan previously worked.

I found these Editorial Expression of Concern (https://link.springer.com/article/10.1007/s12265-020-10076-7) for a paper that Ajan is a co-author. In which it states "Following an investigation into a number of concerns raised in relation to this article after publication, the journal has found that the study did not receive all necessary approvals from regulatory and ethical bodies......our investigation has found that advance approvals were not obtained from the National Ethics Committee nor the National Organizations for Medicines, as required for clinical trials conducted in Greece. "

The Editorial Expression of Concern also states "After reviewing the raw data, discrepancies can be found between the estimated and calculated LVEF data. As this raises questions about the accuracy of the method to determine whether patients met the inclusion criterion of an LVEF of less than 40%, the readers are advised to interpret the findings related to the baseline LVEF data with caution."

Celixir undertook these trial in Greece. So does the 15 years of data that Ajan refers to include the Greece trial that reportedly didn't have all necessary approvals from regulatory and ethical bodies and that readers are advised to interpret the findings related to the baseline LVEF data with caution?

A second Editorial Expression of Concern (EEoC) regarding a different paper that Ajan is a co-author. (https://www.researchgate.net/publication/348851881_Expression_of_Concern_STAT6_knockdown_using_multiple_siRNA_sequences_inhibits_proliferation_and_induces_apoptosis_of_human_colorectal_and_breast_cancer_cell_lines).

This EEoC states "Questions were raised post-publication as to whether the results and conclusions are adequately supported given that the experiments were conducted only in a single cell line per cancer type, lacked some controls, and sample sizes were low (as few as two replicates for some experiments). Questions were also raised about the validity of the statistical analyses reported in the article" and "A statistical reviewer reviewed the article and underlying dataset and raised concerns about the assumptions made about normality and equal variances. The article did not report evidence to support these assumptions or information about how the authors assayed for normality and equal variances."

Have a read of both Editorial Expression of Concerns

So I ask again, where does ROQ get 15 years of data from? For me it just doesn't add up.

Wonder which way this is going when it relists?

I guess it I'll be back in 3 weeks then or if we start to head north rapidly.

Enjoy the sunshine wherever you are.

I think interest will build from the beginning of July though.

If you're away SCS, it's bound to go bonkers with huge flow rate announcement, the JV announcement and a detailed plan to start drilling all being announced in those two weeks.

Enjoy your break though lol

My view is end of July before we know improved flow rates. Roland's inability to hit deadlines and the need to test and tweak will bring us to the end of July

Two buys are two buys, I don't care who, why, when or where. Just keep the £10,000 buys flowing!!!! Lol

Wasn't expected to see an 8% rise today, but my opinion, someone knows the equipment is on the move.

Words are easy, the difficult bit has been producing saleable coal, and until we get May's production figures that remains the case

No one is crying over them. SYN gave a fluffy 90 day 'target' 'deadline' whatever you want to call it. They didn't hit it and by Gordon's estimates it's another 40 days until the date they now give.

The surface pump skid will be ready for airfreighting on June 3rd 2023

The jet pump and modified wellhead will be ready for airfreight shipment to India circa June 5th 2023.

And yes I am going to hold Roland to these dates, so yes I will mention them as they go whooshing by.